Polyphor Announces Closing of Fosun Pharma Licensing Agreement for balixafortide in China and Receipt of $15 Million Upfront Payment

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs